Why the study?
Diminazene aceturate has been described as an ACE2 activator, but its effects on blood pressure in hypertensive and normotensive models required investigation.
Population
Spontaneously hypertensive rats and Wistar Kyoto rats
Comparison
Diminazene aceturate with or without L-NAME or A-779
Design
Preclinical animal and ex vivo study
Authors
Loading...
Hypothesis-generating in hypertensive rat models; human studies needed before any clinical consideration.
Diminazene aceturate acutely reduces blood pressure in spontaneously hypertensive rats through a nitric oxide-mediated mechanism rather than Mas receptor activation.
Sartório et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: